3GGC
Human hypoxanthine-guanine phosphoribosyltransferase in complex with 9-(2-phosphonoethoxyethyl)hypoxanthine
Summary for 3GGC
| Entry DOI | 10.2210/pdb3ggc/pdb |
| Related | 1D6N 1HMP 1Z7G |
| Descriptor | Hypoxanthine-guanine phosphoribosyltransferase, {2-[2-(6-oxo-1,6-dihydro-9H-purin-9-yl)ethoxy]ethyl}phosphonic acid (3 entities in total) |
| Functional Keywords | purine salvage, phosphoribosyltransferase, acyclic nucleoside phosphonate, disease mutation, glycosyltransferase, gout, magnesium, metal-binding, transferase |
| Biological source | Homo sapiens (human) |
| Cellular location | Cytoplasm: P00492 |
| Total number of polymer chains | 2 |
| Total formula weight | 49538.83 |
| Authors | Guddat, L.W.,Keough, D.T.,Jersey, J. (deposition date: 2009-02-27, release date: 2009-08-18, Last modification date: 2023-11-01) |
| Primary citation | Keough, D.T.,Hockova, D.,Holy, A.,Naesens, L.M.,Skinner-Adams, T.S.,Jersey, J.,Guddat, L.W. Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics. J.Med.Chem., 52:4391-4399, 2009 Cited by PubMed Abstract: The purine salvage enzyme hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT) is essential for purine nucleotide and hence nucleic acid synthesis in the malaria parasite, Plasmodium falciparum. Acyclic nucleoside phosphonates (ANPs) are analogues of the nucleotide product of the reaction, comprising a purine base joined by a linker to a phosphonate moiety. K(i) values for 19 ANPs were determined for Pf HGXPRT and the corresponding human enzyme, HGPRT. Values for Pf HGXPRT were as low as 100 nM, with selectivity for the parasite enzyme of up to 58. Structures of human HGPRT in complex with three ANPs are reported. On binding, a large mobile loop in the free enzyme moves to partly cover the active site. For three ANPs, the IC(50) values for Pf grown in cell culture were 1, 14, and 46 microM, while the cytotoxic concentration for the first compound was 489 microM. These results provide a basis for the design of potent and selective ANP inhibitors of Pf HGXPRT as antimalarial drug leads. PubMed: 19527031DOI: 10.1021/jm900267n PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.78 Å) |
Structure validation
Download full validation report
